POSTER SESSION IV
Tuesday, March 1, 2011 — 1:00 PM - 4:30 PM
Exhibit Hall
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
LIVER & PANCREAS PATHOLOGY
Poster#
Title and Authors
Itinerary Planner
195
The Expression of FOXL2 in Pancreatic, Hepatobiliary, and Renal Tumors with Ovarian-Type Stroma.
(1596)
M Westerhoff, M Tretiakova, L Hovan, J Hart, K Gwin, T Antic - University of Chicago, IL
Hepatic Biliary Cystadenoma: A Clinico-Pathological and Immunohistochemical Study.
(1576)
J Ouyang, D Cannan, SC Ward, SN Thung, MI Fiel - The Mount Sinai Medical Center, New York, NY
Invasive Carcinomas Arising from Pancreatic Mucinous Cystic Neoplasms (MCNS) with Ovarian Stroma: A Clinicopathologic Analysis of 25 Cases with Invasive Carcinoma Identified in 131 MCNS.
(1540)
K-T Jang, N Dursun, O Basturk, E Stelow, S Bandyopadhyay, N Adsay - Samsung Medical Center, Seoul, Korea; Emory, GA; MSKCC, NY; U of VA; WSU, MI
IPMNS of the Pancreas and Associated Small Duct Lesions . Analysis of the Distribution of High Grade Dysplasia.
(1598)
GQ Young, N Katabi, E Vakiani, UK Bhanot, DS Klimstra - Memorial Sloan-Kettering Cancer Center, New York, NY
Pancreatic Cyst Fluid Carcinoembryonic Antigen (CEA) Level Obtained by Endoscopic Ultrasound Guided-Fine Needle Aspiration (EUS-FNA) Does Not Predict Grade of Dysplasia in Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas.
(1565)
C McCarty, J Klapman, M Malafa, J Weber, D Coppola, BA Centeno - Moffitt Cancer Center, Tampa, FL
A Novel Monoclonal Antibody, mAb Das-1, Identifies a Colonic Phenotype and Is Specific for Intraductal Papillary Mucinous Neoplasm (IPMN) with a High Risk for Malignant Transformation.
(1519)
KK Das, G Krings, MB Pitman, M Mino-Kenudson - Massachusetts General Hospital, Boston
Phosphorylated FOXO1 Is a Novel Prognostic Factor for Patients with Pancreatic Cancer Receiving Multimodal Therapies.
(1545)
Y-F Jin, M Tomoeda, S Nagata, K Yoshizato, M Kitamura, M Yuki, C Kubo, H Yoshizawa, H Takahashi, H Ohigashi, O Ishikawa, Y Tomita - Osaka Medical Center for Cancer and Cardiovascular Diseases, Japan; Kobe International University, Hyogo, Japan
Primary Pancreatic Adenocarcinoma, Metastatic Lymph Node and Distant Metastasis May Differ in HER2 Expression, Gene Amplification and CEP17 Copy Number: Possible Implications for Diagnostic Evaluation and Therapy.
(1524)
F Fedeli, S Boccardo, P Ferro, N Gorji, P Dessanti, MC Franceschini, M Truini, MP Pistillo, S Salvi, S Roncella - ASL5, La Spezia, Italy; IST, Genova, Italy; AIL "Francesca Lanzone", La Spezia, Italy
The Potential Role of p27, Skp2, and PTEN Expression in Adenocarcinomas of the Ampulla of Vater and Pancreas (AAVP).
(1549)
N Katsiakis, J Maroulis, V Zolota, D Karavias, C Scopa, A Tsamandas - Patras University Medical School, Greece
Prognostic Significance of Prognostic Significance of Cell Cycle Proteins p53, p21, p27, p14, and p16 in Adenocarcinomas of the Ampulla of Vater and Pancreas (AAVP).
(1548)
N Katsiakis, J Maroulis, V Zolota, D Karavias, C Scopa, A Tsamandas - University of Patras, Achaia, Greece
Excision Repair Cross Complementing 1 (ERCC1) and Ribonucleotide Reductase Regulatory Subunit M1 (RRM1) as Predictors of Survival and Response in Pancreatic Ductal Adenocarcinoma Treated with Gemcitabine-Based Chemotherapy.
(1536)
T Holdbrook, KD Danenberg, S Satti, J Kline, CJ Yeo, JR Brody, P McCue, AK Witkiewicz - Thomas Jefferson University Hospital, Philadelphia, PA
Combined Use of Cytology, IMP3 Immunocytochemistry, and Forceps Biopsy Increases the Diagnostic Yield in the Detection of Pancreatico-Biliary Malignancy.
(1535)
J Hart, M Parab, D Mandich, R Cartun, S Ligato - Hartford Hospital, CT
Immunohistochemical Assessment of DCBLD2 and PDZD3 Expression in Pancreatic Ductal Adenocarcinoma.
(1529)
P Gopal, TC Cornish, NB Merchant, RH Hruban, C Shi - Vanderbilt University Medical Center, Nashville, TN; Johns Hopkins University, Baltimore, MD
A and B Glycosiltransferase/Blood Group Antigens in Human Pancreatic Ductal Adenocarcinomas.
(1534)
A Handra-Luca, S Hong, R Hruban, M Goggins - The Johns Hopkins Medical Institutions, Baltimore, MD; APHP Universite Paris 13/Nord UFR SMBH, Bondy Bobigny, France
CK17, MUC5AC, pVHL, and S100P Are the Effective Antibody Panel in Differentiating Intrahepatic Cholangiocarcinoma from Pancreatic Adenocarcinoma.
(1556)
F Lin, J Shi, H Liu, JW Prichard, HL Wang - Geisinger Medical Center, Danville, PA; Cedars-Sinai Medical Center, Los Angeles, CA
Utility of pVHL, Maspin, S100P and IMP3 in Diagnosis of Carcinomas from Various Organs.
(1557)
F Lin, HL Wang, M Wilkerson, H Liu - Geisinger Medical Center, Danville, PA; Cedars-Sinai Medical Center, Los Angeles, CA
Immunohistochemical Study of Maspin for Pancreatic Tumors: Is It Useful for Materials Obtained from Endoscopic Ultrasound Guided-Fine Needle Aspiration?
(1568)
T Mitsuhashi, H Asamuma, T Hayashi, T Hasegawa - Sapporo Medical University, Hokkaido, Japan
The Role of the Soluble Epoxide Hydrolase Expression and K55R Genetic Polymorphism in Pancreatic Ductal Adenocarcionma.
(1521)
X Ding, J Liao, H Li, MS Rao, S Krantz, D Bentrem, G-Y Yang - Northwestern University, Chicago, IL
HuR Regulates IGF1R Expression in Pancreatic Adenocarcinoma.
(1566)
MJ McDonald, J Kline, S Zaheer, V Patel, CJ Yeo, J Brody, AK Witkiewicz - Thomas Jefferson University Hospital, Philadelphia, PA
Vacuolated Cell Pattern as a Diagnostic Feature of Pancreatobiliary Origin for Carcinomas Identified in Liver Biopsies.
(1543)
T Jazaerly, S Bandyopadhyay, O Basturk, N Dursun, B Albashiti, N Culhaci, V Adsay - WSU/DMC/KCI, Detroit, MI; MSKCC, New York; Emory Univ, Atlanta, GA; WSU/DMC, Detroit, MI; Adnan Menderes Univ, Aydin, Turkey
Pathologic Complete Response Is Associated with Good Prognosis in Patient with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Chemoradiation and Pancreatectomy.
(1602)
Q Zhao, A Rashid, Y Gong, M Katz, J Lee, R Wolf, C Charnsangavej, G Varadhachary, P Pisters, E Abdalla, J-N Vauthey, H Wang, H Gomez, J Fleming, J Abbruzzese, H Wang - MD Anderson Cancer Center, Houston, TX
Malignant Perivascular Epithelioid Cell Tumor (PEComa) of the Pancreas: First Report in Patient with BRCA2 Mutation.
(1572)
N Mourra, T Lazure, F Paye, C Colas, L Arrive, A de Gramont, J-F Flejou - Hop. St-Antoine, Paris, France; Hop. Kremlin Bicetre, Kremlin-Bicetre, France, Metropolitan
Hedgehog Signaling Pathway Is Frequently Activated in Pancreatic Neuroendocrine Tumors.
(1527)
WL Frankel, M Bloomston, X Zhou - The Ohio State University, Columbus
Hyaline Globules in Neuroendocrine and Solid-Pseudopapillary Neoplasms of the Pancreas: A Clue to the Diagnosis.
(1567)
Z Meriden, C Shi, B Edil, T Ellison, C Wolfgang, R Schulick, RH Hruban - The Johns Hopkins University School of Medicine, Baltimore, MD
Endoscopic Ultrasound-Guided Fine-Needle Aspiration Cytology of Pancreatic Neuroendocrine Tumors.
(1513)
S Asioli, A Barreca, D Pacchioni, F Maletta, C De Angelis, A Sapino, G Bussolati - University of Turin, Italy
Ki-67 Proliferation Index in Pancreatic Endocrine Tumors: Comparison with Mitotic Count, Interobserver Variability, and Impact on Grading.
(1580)
TA Rege, EE King, JA Barletta, AM Bellizzi - Brigham and Women's Hospital, Boston, MA
button next to any title to add to Itinerary Planner...
Add
